{
  "created_at": "Sat Apr 03 8:52:41 +0000 2021",
  "id_str": "1378184208934387712",
  "full_text": "AstraZeneca's jab is cheap and easy to distribute, so became the vaccine of choice for COVAX. However, it has taken longer than hoped to arrive https://t.co/S0nyxSHNJD",
  "display_text_range": [
    0,
    167
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/S0nyxSHNJD",
        "expanded_url": "https://econ.st/31EpBVE",
        "display_url": "econ.st/31EpBVE",
        "indices": [
          144,
          167
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 33,
  "favorite_count": 85,
  "possibly_sensitive": false,
  "original_created_at": "Sat Apr 03 03:14:55 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "阿斯利康公司的注射液价格便宜，易于配送，所以成为COVAX的首选疫苗。然而，它到达的时间比希望的要长https://t.co/S0nyxSHNJD。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "阿斯利康公司的注射液價格便宜，易於配送，所以成爲COVAX的首選疫苗。然而，它到達的時間比希望的要長https://t.co/S0nyxSHNJD。"
    },
    {
      "locale": "ja-JA",
      "full_text": "アストラゼネカ社のジャブは安価で配布しやすいため、COVAXのワクチンとして選ばれました。しかし、期待以上に到着に時間がかかりました。https://t.co/S0nyxSHNJD"
    },
    {
      "locale": "ja",
      "full_text": "アストラゼネカ社のジャブは安価で配布しやすいため、COVAXのワクチンとして選ばれました。しかし、期待以上に到着に時間がかかりました。https://t.co/S0nyxSHNJD"
    }
  ]
}